745 related articles for article (PubMed ID: 31991222)
1. Whole-genome sequencing in drug susceptibility testing of Mycobacterium tuberculosis in routine practice in Lyon, France.
Genestet C; Hodille E; Berland JL; Ginevra C; Bryant JE; Ader F; Lina G; Dumitrescu O;
Int J Antimicrob Agents; 2020 Apr; 55(4):105912. PubMed ID: 31991222
[TBL] [Abstract][Full Text] [Related]
2. Occurrence of disputed rpoB mutations among Mycobacterium tuberculosis isolates phenotypically susceptible to rifampicin in a country with a low incidence of multidrug-resistant tuberculosis.
Al-Mutairi NM; Ahmad S; Mokaddas E; Eldeen HS; Joseph S
BMC Infect Dis; 2019 Jan; 19(1):3. PubMed ID: 30606116
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
[TBL] [Abstract][Full Text] [Related]
4. Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance Escalation.
Ocheretina O; Shen L; Escuyer VE; Mabou MM; Royal-Mardi G; Collins SE; Pape JW; Fitzgerald DW
PLoS One; 2015; 10(6):e0129207. PubMed ID: 26039194
[TBL] [Abstract][Full Text] [Related]
5. Genotypic and phenotypic comparison of drug resistance profiles of clinical multidrug-resistant Mycobacterium tuberculosis isolates using whole genome sequencing in Latvia.
Vīksna A; Sadovska D; Berge I; Bogdanova I; Vaivode A; Freimane L; Norvaiša I; Ozere I; Ranka R
BMC Infect Dis; 2023 Sep; 23(1):638. PubMed ID: 37770850
[TBL] [Abstract][Full Text] [Related]
6. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
[TBL] [Abstract][Full Text] [Related]
7. Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.
Prommi A; Wongjarit K; Petsong S; Somsukpiroh U; Faksri K; Kawkitinarong K; Payungporn S; Rotcheewaphan S
Microbiol Spectr; 2024 Mar; 12(3):e0346223. PubMed ID: 38323824
[TBL] [Abstract][Full Text] [Related]
8. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Wu X; Gao R; Shen X; Guo Y; Yang J; Wu Z; Tan G; Wang H; Yu F
Int J Infect Dis; 2020 Jul; 96():48-53. PubMed ID: 32339720
[TBL] [Abstract][Full Text] [Related]
9. A Diagnostic Algorithm To Investigate Pyrazinamide and Ethambutol Resistance in Rifampin-Resistant Mycobacterium tuberculosis Isolates in a Low-Incidence Setting.
Andres S; Gröschel MI; Hillemann D; Merker M; Niemann S; Kranzer K
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455227
[TBL] [Abstract][Full Text] [Related]
10. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
Al-Mutairi NM; Ahmad S; Mokaddas E
Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
[TBL] [Abstract][Full Text] [Related]
11. Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Indonesia.
Chaidir L; Ruesen C; Dutilh BE; Ganiem AR; Andryani A; Apriani L; Huynen MA; Ruslami R; Hill PC; van Crevel R; Alisjahbana B
J Glob Antimicrob Resist; 2019 Mar; 16():170-177. PubMed ID: 30172045
[TBL] [Abstract][Full Text] [Related]
12. Utility of the REBA MTB-Rifa® assay for rapid detection of rifampicin resistant Mycobacterium tuberculosis.
Cho E; Shamputa IC; Kwak HK; Lee J; Lee M; Hwang S; Jeon D; Kim CT; Cho S; Via LE; Barry CE; Lee JS
BMC Infect Dis; 2013 Oct; 13():478. PubMed ID: 24128118
[TBL] [Abstract][Full Text] [Related]
13. Genotypic drug resistance using whole-genome sequencing of Mycobacterium tuberculosis clinical isolates from North-western Tanzania.
Kidenya BR; Mshana SE; Fitzgerald DW; Ocheretina O
Tuberculosis (Edinb); 2018 Mar; 109():97-101. PubMed ID: 29559127
[TBL] [Abstract][Full Text] [Related]
14. Whole-genome sequence analysis and comparisons between drug-resistance mutations and minimum inhibitory concentrations of Mycobacterium tuberculosis isolates causing M/XDR-TB.
Nonghanphithak D; Kaewprasert O; Chaiyachat P; Reechaipichitkul W; Chaiprasert A; Faksri K
PLoS One; 2020; 15(12):e0244829. PubMed ID: 33382836
[TBL] [Abstract][Full Text] [Related]
15. Whole-genome sequencing of clinical isolates from tuberculosis patients in India: real-world data indicates a high proportion of pre-XDR cases.
Bhanushali A; Atre S; Nair P; Thandaseery GA; Shah S; Kuruwa S; Zade A; Nikam C; Gomare M; Chatterjee A
Microbiol Spectr; 2024 May; 12(5):e0277023. PubMed ID: 38597637
[TBL] [Abstract][Full Text] [Related]
16. Whole genome sequencing to complement tuberculosis drug resistance surveys in Uganda.
Ssengooba W; Meehan CJ; Lukoye D; Kasule GW; Musisi K; Joloba ML; Cobelens FG; de Jong BC
Infect Genet Evol; 2016 Jun; 40():8-16. PubMed ID: 26917365
[TBL] [Abstract][Full Text] [Related]
17. [Detection of tuberculosis genes associated with drug-resistance in paraffin-embedded tissue specimens using next generation sequencing technology].
Song J; Zhang ZG; Dong YJ; Du WL; Wang YX; Liu ZC; Li K; Zhang Q; Sun Q; Che NY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):234-241. PubMed ID: 32164095
[No Abstract] [Full Text] [Related]
18. WGS more accurately predicts susceptibility of Mycobacterium tuberculosis to first-line drugs than phenotypic testing.
Jajou R; van der Laan T; de Zwaan R; Kamst M; Mulder A; de Neeling A; Anthony R; van Soolingen D
J Antimicrob Chemother; 2019 Sep; 74(9):2605-2616. PubMed ID: 31119271
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Whole Genome Sequencing-Based Predictions of Antimicrobial Resistance to TB First Line Agents: A Lesson from 5 Years of Data.
Sharma MK; Stobart M; Akochy PM; Adam H; Janella D; Rabb M; Alawa M; Sekirov I; Tyrrell GJ; Soualhine H
Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
